Clinical Trials in Detroit

Showing 7321-7340 of 19,719 trials

Nonopioid Analgesia After Rotator Cuff Repair

NCT03818919

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Rotator Cuff Tear

Henry Ford Health System70 participantsStarted Jan 2019

Detroit, Michigan, United States

TERMINATED< 1 mile

REDAPT Retrospective-Prospective Modular Stem Study

NCT02661620

A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study design to provide data on the post market performance and safety of the study device. The study will collect retrospective data from medical records review and prospective data from observations data at 5 and 10 postoperatively clinical visits. There will also be a 7.5 year telephone follow up contact to assess for device status and adverse events.

Arthroplasties, Hip Replacement

Smith & Nephew, Inc.140 participantsStarted Feb 2016

Louisville, Kentucky, United States • Detroit, Michigan, United States • Portland, Oregon, United States +2 more locations

Nonopioid Analgesia After Rotator Cuff Repair

REDAPT Retrospective-Prospective Modular Stem Study

Find Trials by Condition in Detroit

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

The Ontario Neurodegenerative Disease Research Initiative

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

The Impact of Dosing Parameters on Motor Skill Acquisition and Retention in Bilateral Cerebral Palsy (BCP)

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients